Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation | BMC Medical Genetics | Full Text

Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation | BMC Medical Genetics | Full Text



BMC Medical Genetics

Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation

• Jayesh ShethEmail authorView ORCID ID profile,
• Riddhi Bhavsar,
• Mehul Mistri,
• Dhairya Pancholi,
• Ashish Bavdekar,
• Ashwin Dalal,
• Prajnya Ranganath,
• Katta M Girisha,
• Anju Shukla,
• Shubha Phadke,
• Ratna Puri,
• Inusha Panigrahi,
• Anupriya Kaur,
• Mamta Muranjan,
• Manisha Goyal,
• Radha Ramadevi,
• Raju Shah,
• Sheela Nampoothiri,
• Sumita Danda,
• Chaitanya Datar,
• Seema Kapoor,
• Seema Bhatwadekar and
• Frenny Sheth

BMC Medical Genetics201920:31

https://doi.org/10.1186/s12881-019-0759-1

©  The Author(s). 2019

• Received: 29 October 2018
• Accepted: 22 January 2019
• Published: 14 February 2019

Open Peer Review reports

Abstract

Background

Gaucher disease is a rare pan-ethnic, lysosomal storage disorder resulting due to beta-Glucosidase (GBA1) gene defect. This leads to the glucocerebrosidase enzyme deficiency and an increased accumulation of undegraded glycolipid glucocerebroside inside the cells’ lysosomes. To date, nearly 460 mutations have been described in the GBA1 gene. With the aim to determine mutations spectrum and molecular pathology of Gaucher disease in India, the present study investigated one hundred unrelated patients (age range: 1 day to 31 years) having splenomegaly, with or without hepatomegaly, cytopenia and bone abnormality in some of the patients.

Methods

The biochemical investigation for the plasma chitotriosidase enzyme activity and β-Glucosidase enzyme activity confirmed the Gaucher disease. The mutations were identified by screening the patients’ whole GBA gene coding region using bidirectional Sanger sequencing.

Results

The biochemical analysis revealed a significant reduction in the β-Glucosidase activity in all patients. Sanger sequencing established 71 patients with homozygous mutation and 22 patients with compound heterozygous mutation in GBA1 gene. Lack of identification of mutations in three patients suggests the possibility of either large deletion/duplication or deep intronic variations in the GBA1 gene. In four cases, where the proband died due to confirmed Gaucher disease, the parents were found to be a carrier. Overall, the study identified 33 mutations in 100 patients that also covers four missense mutations (p.Ser136Leu, p.Leu279Val, p.Gly383Asp, p.Gly399Arg) not previously reported in Gaucher disease patients. The mutation p.Leu483Pro was identified as the most commonly occurring Gaucher disease mutation in the study (62% patients). The second common mutations identified were p.Arg535Cys (7% patients) and RecNcil (7% patients). Another complex mutation Complex C was identified in a compound heterozygous status (3% patients). The homology modeling of the novel mutations suggested the destabilization of the GBA protein structure due to conformational changes.

Conclusions

The study reports four novel and 29 known mutations identified in the GBA1 gene in one-hundred Gaucher patients. The given study establishes p.Leu483Pro as the most prevalent mutation in the Indian patients with type 1 Gaucher disease that provide new insight into the molecular basis of Gaucher Disease in India.

Keywords

• Gaucher disease
• β-Glucosidase
• Chitotriosidase
• GBA1 gene
• Glucocerebrosidase
• Indian population
• p.Leu483Pro most common mutation
• novel mutations in GBA1 gene